Risankizumab: Solution concentrate for I.V. infusion 600 mg in 10 mL, Injection 360 mg in 2.4 mL in pre-filled cartridge; Skyrizi® - July 2022 – November 2022 PBAC meetings Page last updated: 3 March 2023 Public Summary Document (PSD) July 2022 November 2022 PBAC Meetings - (PDF 967KB) Public Summary Document (PSD) July 2022 November 2022 PBAC Meetings - (Word 384KB)